Missing: ADCendo's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ADCendo's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing ADCendo
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ADCendo is included in 1 Expert Collection, including Cancer.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Latest ADCendo News
May 4, 2022
MAY 03, 2022 | 6:42 PM PDT | BIOCENTURY | MANAGEMENT TRACKSHICKEY RETURNS TO U.S. FOR NEW ROLE AT PFIZERBY Plus Ksundinya named president and CEO at GlycoERA, and updates from Plexium, Alentis, ADCendo, Xcell and morehttps://www.biocentury.com/article/643456/hickey-returns-to-u-s-for-new-role-at-pfizer© 2022 BioCentury Inc. All Rights Reserved
ADCendo Frequently Asked Questions (FAQ)
When was ADCendo founded?
ADCendo was founded in 2017.
Where is ADCendo's headquarters?
ADCendo's headquarters is located at BioInnovation Institute, Copenhagen.
What is ADCendo's latest funding round?
ADCendo's latest funding round is Series A.
How much did ADCendo raise?
ADCendo raised a total of $62.55M.
Who are the investors of ADCendo?
Investors of ADCendo include Ysios Capital Partners, Gilde Healthcare, RA Capital Management, Novo Seeds, HealthCap Venture Capital and 3 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.